1. A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery

   Reeßing, F., Stuart, M. C. A., Samplonius, D. F., Dierckx, R. A. J. O., Feringa, B. L., Helfrich, W. & Szymanski, W., 16-Sep-2019, In : Chemical communications (Cambridge, England). 55, 72, p. 10784-10787 4 p.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Bispecific antibody approach for improved melanoma-selective PD-L1 immune checkpoint blockade

   Koopmans, I., Hendriks, M. A. J. M., van Ginkel, R. J., Samplonius, D. F., Bremer, E. & Helfrich, W., 23-May-2019, In : Journal of Investigative Dermatology. 39 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapy.

   Bremer, E. & Helfrich, W., 1-Jan-2006, In : Discovery medicine. 6, 33, p. 113-117 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Development of Bispecific Antibody Derivatives for Cancer Immunotherapy

   He, Y., Helfrich, W. & Bremer, E., 2019, Cancer Immunosurveillance: Methods and Protocols. Humana Press, p. 335-347 13 p. (Methods in Molecular Biology).

   Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

5. Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition

   de Boer, H. R., Pool, M., Joosten, E., Everts, M., Samplonius, D. F., Helfrich, W., Groen, H. J. M., van Cooten, S., Fusetti, F., Fehrmann, R. S. N., de Vries, E. G. E. & van Vugt, M. A. T. M., 28-Feb-2019, In : ONCOGENE. 38, 9, p. 1477-1488 12 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (105) »